Hepatotoxins Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hepatotoxins stocks.

Symbol Grade Name Weight

View all Hepatotoxins related ETFs...

Compare ETFs

    Recent Signals

    Date Stock Signal Type
    2021-04-14 ATBPF Lower Bollinger Band Walk Weakness
    2021-04-14 ATBPF Narrow Range Bar Range Contraction
    2021-04-14 MLPH Crossed Above 200 DMA Bullish
    2021-04-14 MLPH Narrow Range Bar Range Contraction
    2021-04-14 MLPH Stochastic Buy Signal Bullish
    2021-04-14 MLPH Crossed Above 20 DMA Bullish
    2021-04-14 MLPH Crossed Above 50 DMA Bullish
    2021-04-14 PANC Stochastic Buy Signal Bullish
    2021-04-14 PANC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-04-14 PANC Pocket Pivot Bullish Swing Setup
    2021-04-14 PANC Narrow Range Bar Range Contraction
    2021-04-14 PANC Volume Surge Other

    Recent News for Hepatotoxins Stocks

    Date Stock Title

    Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. Drug-induced liver injury is a cause of acute and chronic liver disease.
    The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents. Certain medicinal agents, when taken in overdoses and sometimes even when introduced within therapeutic ranges, may injure the organ. Other chemical agents, such as those used in laboratories and industries, natural chemicals (e.g., microcystins) and herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are called hepatotoxins.
    More than 900 drugs have been implicated in causing liver injury (see LiverTox, external link, below) and it is the most common reason for a drug to be withdrawn from the market. Hepatotoxicity and drug-induced liver injury also account for a substantial number of compound failures, highlighting the need for toxicity prediction models (e.g. DTI), and drug screening assays, such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process. Chemicals often cause subclinical injury to the liver, which manifests only as abnormal liver enzyme tests.
    Drug-induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures.

    More about Hepatotoxins
    Browse All Tags